作者: Iolanda Jordan Garcia , Mònica B. Gargallo , Elisabeth E. Torné , Francisco José Cambra Lasaosa , Anna T. Viñas
DOI: 10.1097/PCC.0B013E31823890DE
关键词: Procalcitonin 、 Medicine 、 Gastroenterology 、 Surgery 、 Internal medicine 、 Biomarker (medicine) 、 Intensive care unit 、 Prospective cohort study 、 Systemic inflammatory response syndrome 、 Cardiopulmonary bypass 、 Infectious complication 、 Optimal cutoff
摘要: OBJECTIVE To determine whether procalcitonin discriminates between postcardiopulmonary bypass inflammatory syndrome and infectious complication in children better than does C-reactive protein. DESIGN Prospective study of admitted to the intensive care unit after cardiopulmonary bypass. PATIENTS Classified according a diagnosis systemic response bacterial infection or but no infection. Two hundred thirty-one cases were recruited. MEASUREMENT AND MAIN RESULTS Procalcitonin, protein, leukocyte count measured daily from surgery until day 3. Twenty-two patients infected (9.5%). Significant differences detected values group vs. noninfected group, especially at 2 (p = .000). There protein values. The optimal cutoff for was >2 ng/mL 1 above 4 2. greater sensitivity specificity with as an predictor. CONCLUSION Procalcitonin is useful Because kinetics are different patients, diagnose should be normal cutoff.